In Vivo Models for Prostate Cancer Research

Area of Science:

• Oncology
• Genetics
• Animal Models

Background:

• Prostate cancer (PCa) is the most common cancer diagnosis in US men.
• Understanding PCa progression requires effective preclinical models.
• Mouse models are crucial due to genomic similarities with humans.

Purpose of the Study:

• To compare and contrast various in vivo models of prostate cancer.
• To analyze genetic alterations, signaling pathways, and tumor progression in PCa models.
• To evaluate the utility of different models for translating findings to human PCa.

Main Methods:

• Review of genetically engineered mouse models (conditional/constitutive knockouts).
• Inclusion of 2D cell lines, 3D organoids/spheroids, xenografts, allografts, and patient-derived models.
• Analysis of model applications, advantages, disadvantages, cost, and ease of use.

Main Results:

• Different models offer unique applications, benefits, and drawbacks.
• All models facilitate the translation of mouse prostate tumor progression to human relevance.
• The inability of native mouse prostates to spontaneously form carcinoma is a key consideration.

Conclusions:

• Various in vivo models significantly advance our understanding of prostate cancer.
• Genomic similarities between mice and humans enhance the translational value of PCa models.
• Continued research using these models will expand knowledge of PCa.